ExSight Ventures - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2014
ExSight Ventures is a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions. The firm focuses on biotechnology, medical devices, pharmaceuticals, and software solutions within the ophthalmology sector. ExSight Ventures typically invests in Series A, B, and C rounds, providing crucial funding to companies developing groundbreaking technologies in eye care.
Notable portfolio companies include ONL Therapeutics, Trefoil Therapeutics, and Valitor, which have collectively raised significant capital to advance their innovative treatments. The firm is led by two accomplished retinal surgeons and a team of investment professionals dedicated to addressing the funding needs of early-stage ophthalmic-focused companies. ExSight Ventures offers unique value-add services through its deep industry expertise and extensive network in the ophthalmology field.
ExSight Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
